Genetic and Antigenic Variability in VP4 and VP7 of Group A Human Rotavirus in Yunnan, China, from 2015 to 2020
Background: Rotavirus (RV) A is one of the major reasons which causes acute dehydration and diarrhea. It is also one of the highest morbid diseases in children. There are only a few reports about the changes in prevalence and VP4/VP7 genotype of RVs in southwest China. Here is the report about the p...
Saved in:
Published in | Intervirology Vol. 68; no. 1; pp. 43 - 56 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
S. Karger AG
29.04.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Rotavirus (RV) A is one of the major reasons which causes acute dehydration and diarrhea. It is also one of the highest morbid diseases in children. There are only a few reports about the changes in prevalence and VP4/VP7 genotype of RVs in southwest China. Here is the report about the prevalence of RVs from 2015 to 2020 in Yunnan, southwest China. Methods: The virus genes were extracted from RV positive samples, then VP4/VP7 genes were amplified, followed by sequencing and gene typing, phylogenetic analysis, antigenic epitope variation analysis, and selective pressure analysis were also performed. Results: A total of 135 VP4 gene sequences and 143 VP7 gene sequences were obtained from stool samples during 2015–2020. Of them, P[8] genotype accounted for 97.0% of the total, while the P[4] genotype accounted for 3.0%. As for the VP7 genotype, G9 genotype accounted for 86.0% of the total, the G3 genotype accounted for 9.1%, and the G2 genotype accounted for 4.9%. G9P[8] was identified as the predominant RV strain during the epidemic season in Yunnan during 2015–2020. Phylogenetic analysis showed that G9 genotype sequences were primarily similar to African strains (KJ753473, KY661937), while P[8] genotype sequences were close to Southeast Asian strains (JQ837878, KX362594). In antigenic epitope variation analysis, among 37 epitopes of P[8] genotype, the RotaTeq™ vaccine strain covers 31 amino acid positions, Rotarix™ covers 28 amino acid positions, while LLR covers only 9. In the representative sequence of the G9 genotype, RotaTeq™ vaccine strains cover 27 out of 29 amino acid positions, Rotarix™ covers 16 positions, and LLR covers 16 positions. The results of the selective pressure analysis indicated potential positive sites for the G9P[8] genotype located at vp7-44, vp7-100, vp7-221, vp7-278, vp4-3, and vp4-4. Conclusions: Our study shows that G9P[8] is the most dominant RV genotype in Yunnan, China. Consistent with the recent epidemic trend of RV strains in China, this study could provide new perspectives on vaccine research. |
---|---|
AbstractList | Rotavirus (RV) A is one of the major reasons which causes acute dehydration and diarrhea. It is also one of the highest morbid diseases in children. There are only a few reports about the changes in prevalence and VP4/VP7 genotype of RVs in southwest China. Here is the report about the prevalence of RVs from 2015 to 2020 in Yunnan, southwest China.
The virus genes were extracted from RV positive samples, then VP4/VP7 genes were amplified, followed by sequencing and gene typing, phylogenetic analysis, antigenic epitope variation analysis, and selective pressure analysis were also performed.
A total of 135 VP4 gene sequences and 143 VP7 gene sequences were obtained from stool samples during 2015-2020. Of them, P[8] genotype accounted for 97.0% of the total, while the P[4] genotype accounted for 3.0%. As for the VP7 genotype, G9 genotype accounted for 86.0% of the total, the G3 genotype accounted for 9.1%, and the G2 genotype accounted for 4.9%. G9P[8] was identified as the predominant RV strain during the epidemic season in Yunnan during 2015-2020. Phylogenetic analysis showed that G9 genotype sequences were primarily similar to African strains (KJ753473, KY661937), while P[8] genotype sequences were close to Southeast Asian strains (JQ837878, KX362594). In antigenic epitope variation analysis, among 37 epitopes of P[8] genotype, the RotaTeq™ vaccine strain covers 31 amino acid positions, Rotarix™ covers 28 amino acid positions, while LLR covers only 9. In the representative sequence of the G9 genotype, RotaTeq™ vaccine strains cover 27 out of 29 amino acid positions, Rotarix™ covers 16 positions, and LLR covers 16 positions. The results of the selective pressure analysis indicated potential positive sites for the G9P[8] genotype located at vp7-44, vp7-100, vp7-221, vp7-278, vp4-3, and vp4-4.
Our study shows that G9P[8] is the most dominant RV genotype in Yunnan, China. Consistent with the recent epidemic trend of RV strains in China, this study could provide new perspectives on vaccine research. Background: Rotavirus (RV) A is one of the major reasons which causes acute dehydration and diarrhea. It is also one of the highest morbid diseases in children. There are only a few reports about the changes in prevalence and VP4/VP7 genotype of RVs in southwest China. Here is the report about the prevalence of RVs from 2015 to 2020 in Yunnan, southwest China. Methods: The virus genes were extracted from RV positive samples, then VP4/VP7 genes were amplified, followed by sequencing and gene typing, phylogenetic analysis, antigenic epitope variation analysis, and selective pressure analysis were also performed. Results: A total of 135 VP4 gene sequences and 143 VP7 gene sequences were obtained from stool samples during 2015–2020. Of them, P[8] genotype accounted for 97.0% of the total, while the P[4] genotype accounted for 3.0%. As for the VP7 genotype, G9 genotype accounted for 86.0% of the total, the G3 genotype accounted for 9.1%, and the G2 genotype accounted for 4.9%. G9P[8] was identified as the predominant RV strain during the epidemic season in Yunnan during 2015–2020. Phylogenetic analysis showed that G9 genotype sequences were primarily similar to African strains (KJ753473, KY661937), while P[8] genotype sequences were close to Southeast Asian strains (JQ837878, KX362594). In antigenic epitope variation analysis, among 37 epitopes of P[8] genotype, the RotaTeq™ vaccine strain covers 31 amino acid positions, Rotarix™ covers 28 amino acid positions, while LLR covers only 9. In the representative sequence of the G9 genotype, RotaTeq™ vaccine strains cover 27 out of 29 amino acid positions, Rotarix™ covers 16 positions, and LLR covers 16 positions. The results of the selective pressure analysis indicated potential positive sites for the G9P[8] genotype located at vp7-44, vp7-100, vp7-221, vp7-278, vp4-3, and vp4-4. Conclusions: Our study shows that G9P[8] is the most dominant RV genotype in Yunnan, China. Consistent with the recent epidemic trend of RV strains in China, this study could provide new perspectives on vaccine research. Rotavirus(RVs) A is one of major reasons which causes severe dehydration diarrhea. It is also one of the high morbidity disease in children. There are only a few reports about the changes in prevalence and VP4 / VP7 genotype of RVs in southwest China.Here is the report about the prevalence of RV from 2015 to 2020 in Yunnan, southwest China.BACKGROUNDRotavirus(RVs) A is one of major reasons which causes severe dehydration diarrhea. It is also one of the high morbidity disease in children. There are only a few reports about the changes in prevalence and VP4 / VP7 genotype of RVs in southwest China.Here is the report about the prevalence of RV from 2015 to 2020 in Yunnan, southwest China.The virus genes were extracted from RV positive samples, then VP4/VP7 genes were amplified, followed by sequencing and Gene typing, Phylogenetic analysis, antigenic epitope variation analysis and selective pressure analysis were also performed.METHODSThe virus genes were extracted from RV positive samples, then VP4/VP7 genes were amplified, followed by sequencing and Gene typing, Phylogenetic analysis, antigenic epitope variation analysis and selective pressure analysis were also performed.135 VP4 gene sequences and 143 VP7 gene sequences were obtained from stool samples during 2015 to 2020. Of them, P[8] genotype accounted for 97.0% of total, while the P[4] genotype accounted for 3.0%. As for the VP7 genotype, G9 genotype accounted for 86.0% of total, the G3 genotype accounted for 9.1%, and the G2 genotype accounted for 4.9%. G9P[8] was identified as the predominant RV strain during the epidemic season in Yunnan during 2015 to 2020. Phylogenetic analysis showed that G9 genotype sequences were primarily similar to African strains (KJ753473, KY661937), while P[8] genotype sequences were close to Southeast Asian strains (JQ837878, KX362594). In antigenic epitope variation analysis, among 37 epitope of P[8] genotype, the RotaTeq™ vaccine strain covers 31 amino acid positions, Rotarix™ covers 28 amino acid positions, while LLR covers only 9. In the representative sequence of the G9 genotype, RotaTeq™ vaccine strains cover 27 out of 29 amino acid positions, Rotarix™ cover 16 positions, and LLR cover 16 positions. The results of the selective pressure analysis indicated potential positive sites for the G9P[8] genotype located at vp7-44, vp7-100, vp7-221, vp7-278, vp4-3 and vp4-4.RESULTS135 VP4 gene sequences and 143 VP7 gene sequences were obtained from stool samples during 2015 to 2020. Of them, P[8] genotype accounted for 97.0% of total, while the P[4] genotype accounted for 3.0%. As for the VP7 genotype, G9 genotype accounted for 86.0% of total, the G3 genotype accounted for 9.1%, and the G2 genotype accounted for 4.9%. G9P[8] was identified as the predominant RV strain during the epidemic season in Yunnan during 2015 to 2020. Phylogenetic analysis showed that G9 genotype sequences were primarily similar to African strains (KJ753473, KY661937), while P[8] genotype sequences were close to Southeast Asian strains (JQ837878, KX362594). In antigenic epitope variation analysis, among 37 epitope of P[8] genotype, the RotaTeq™ vaccine strain covers 31 amino acid positions, Rotarix™ covers 28 amino acid positions, while LLR covers only 9. In the representative sequence of the G9 genotype, RotaTeq™ vaccine strains cover 27 out of 29 amino acid positions, Rotarix™ cover 16 positions, and LLR cover 16 positions. The results of the selective pressure analysis indicated potential positive sites for the G9P[8] genotype located at vp7-44, vp7-100, vp7-221, vp7-278, vp4-3 and vp4-4.Our study shows that G9P [8] is the most dominant rotavirus genotype in Yunnan China. Consistent with the recent epidemic trend of RV strains in China, this study could provide new perspectives on vaccine research.CONCLUSIONSOur study shows that G9P [8] is the most dominant rotavirus genotype in Yunnan China. Consistent with the recent epidemic trend of RV strains in China, this study could provide new perspectives on vaccine research. |
Author | Qiu, Lijuan Ma, Haoyu Long, Shuying Jiang, Hongchao Chuan, Liufang Zhao, Canchun Zhang, Zhen Sun, Qiangming Wang, Meifen |
Author_xml | – sequence: 1 givenname: Haoyu surname: Ma fullname: Ma, Haoyu – sequence: 2 givenname: Meifen surname: Wang fullname: Wang, Meifen – sequence: 3 givenname: Liufang surname: Chuan fullname: Chuan, Liufang – sequence: 4 givenname: Shuying surname: Long fullname: Long, Shuying – sequence: 5 givenname: Lijuan surname: Qiu fullname: Qiu, Lijuan – sequence: 6 givenname: Canchun surname: Zhao fullname: Zhao, Canchun – sequence: 7 givenname: Qiangming surname: Sun fullname: Sun, Qiangming – sequence: 8 givenname: Zhen surname: Zhang fullname: Zhang, Zhen – sequence: 9 givenname: Hongchao surname: Jiang fullname: Jiang, Hongchao |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40300562$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkV1r2zAYhUVpWdNsF_0DRZcr1Ks-LNm-GiG06aDQUtZAr8RrWUo0bCmT7ED-fZ1-hO3q8PI-nAPnnKFjH7xB6JySH5SK6poQInJJpDhCE5oznhFKyDGaEE5IJgSTp-gspT8jxiknX9Bpvv8IySYoLIw3vdMYfINnvncr48drCdFB7VrX77DzePmYvwHLxwIHixcxDBs8w3dDBx4_hR62Lg5pT74M3oO_wvO183CFbQwdZoQK3IdRGfmKTiy0yXz70Cl6vr35Pb_L7h8Wv-az-0xzXvYZrWxZ2kZWumS8gFJI2RjLwMq6ZFSaugYtRMFtYyrBQOtScgnMNlA0wrCcT9HPd9_NUHem0cb3EVq1ia6DuFMBnPr_491arcJWUTYGsjF1ir5_OMTwdzCpV51L2rQteBOGpDitCjkWKeSIXvwbdkj5rHkELt8BHUNK0dgDQonaT6gOE_JXt7aKvA |
Cites_doi | 10.3390/vaccines8030341 10.1186/s12879-022-07542-9 10.1186/s12879-021-05795-4 10.1016/j.vaccine.2018.08.081 10.1097/00006454-198603000-00012 10.1002/jmv.27806 10.2807/1560-7917.ES.2019.24.15.1800418 10.1136/archdischild-2017-313163 10.1002/jmv.25214 10.1016/j.vaccine.2018.08.046 10.3201/eid2803.212117 10.1093/jpids/piw071 10.1016/j.vaccine.2019.03.069 10.1007/s44197-022-00050-8 10.1016/j.jinf.2015.03.001 10.1186/s12879-020-05279-x 10.1016/j.cmi.2016.06.007 10.1080/21645515.2020.1801071 10.4415/ANN_13_02_03 10.1590/0037-8682-0023-2015 10.1093/cid/ciy1096 10.11604/PAMJ.SUPP.2017.28.1.2486 10.1002/rmv.2020 10.1186/s12929-020-00649-8 10.1016/j.lanwpc.2021.100268 10.1136/BMJ-2021-066169 10.4269/ajtmh.18-0763 10.1186/s12879-018-3411-3 10.1371/journal.pone.0242813 10.1007/s00705-023-05849-9 10.1186/s12879-020-05448-y 10.1099/jgv.0.000807 10.1186/s12879-020-05230-0 10.1016/j.vaccine.2018.05.031 10.1017/S0950268820002320 10.2807/1560-7917.ES.2019.24.6.1700774 10.1016/j.vaccine.2014.06.018 10.1016/j.cmi.2017.10.009 10.1002/jmv.25530 10.3390/tropicalmed8020101 10.1007/s00705-013-1663-1 10.1016/j.jinf.2021.09.007 10.1186/s12879-020-05718-9 10.1002/jmv.25067 10.1053/j.spid.2006.08.005 10.1007/s12250-018-0043-0 10.1016/j.heliyon.2023.e18236 10.7717/peerj.10954 10.3390/ijms241512189 10.1016/j.vaccine.2019.09.022 10.1186/s12889-019-6406-0 10.1016/j.jes.2017.07.015 10.1128/JVI.02076-17 10.1002/ece3.5015 10.2165/11207130-000000000-00000 10.1001/jamapediatrics.2018.1960 10.1073/pnas.2013182117 |
ContentType | Journal Article |
Copyright | 2025 The Author(s). Published by S. Karger AG, Basel. The Author(s). Published by S. Karger AG, Basel. 2025 The Author(s). Published by S. Karger AG, Basel 2025 |
Copyright_xml | – notice: 2025 The Author(s). Published by S. Karger AG, Basel. – notice: The Author(s). Published by S. Karger AG, Basel. – notice: 2025 The Author(s). Published by S. Karger AG, Basel 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1159/000546065 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Prevalence of RV from 2015 to 2020 in Yunnan |
EISSN | 1423-0100 |
EndPage | 56 |
ExternalDocumentID | PMC12237282 40300562 10_1159_000546065 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- -~X 0~B 326 36B 3O. 4.4 5GY 5RE AAYIC AAYXX ABBTS ABPAZ ABWCG ACGFS ACGOD ACPRK ACPSR ADBBV ADFRT AENEX AEYAO AHFRZ AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AZPMC BENPR CITATION CS3 DU5 E0A EBS EMB EMOBN F5P FB. GROUPED_DOAJ HCIFZ HZ~ IAO IY7 KUZGX L7B M-- M7P N9A O1H O9- OK1 RKO SV3 UJ6 .GJ 0~5 29J 30W 34G 39C 3O- 53G 7X7 88E 88I 8AF 8AO 8FE 8FH 8FI 8FJ 8UI ABJNI ABUWG ACQXL ADAGL AFFNX AFJJK AFKRA AFSIO AI. AIOBO AZQEC BBNVY BHPHI BPHCQ BVXVI CAG CCPQU CGR COF CUY CVF CYUIP DWQXO ECM EIF EJD FYUFA GNUQQ HMCUK IHR INH ITC LK8 M1P M2P NPM OHT PHGZM PHGZT PPXIY PQGLB PQQKQ PROAC PSQYO RIG RXVBD S0X UKHRP VH1 ZGI ZXP 7X8 5PM |
ID | FETCH-LOGICAL-c338t-19f88fd69c8237a8566def2af6b8216ebbac5573fde952acc8636a2fda7d5e243 |
ISSN | 0300-5526 1423-0100 |
IngestDate | Thu Aug 21 18:23:29 EDT 2025 Thu May 01 02:03:17 EDT 2025 Sat Jul 12 02:48:56 EDT 2025 Wed Jul 16 16:36:01 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Phylogenetic analysis Prevalence Rotavirus A Antigen epitope variation |
Language | English |
License | https://creativecommons.org/licenses/by-nc/4.0 2025 The Author(s). Published by S. Karger AG, Basel. This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c338t-19f88fd69c8237a8566def2af6b8216ebbac5573fde952acc8636a2fda7d5e243 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Haoyu Ma and Meifen Wang contributed equally to this article. |
OpenAccessLink | http://dx.doi.org/10.1159/000546065 |
PMID | 40300562 |
PQID | 3197640356 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_12237282 proquest_miscellaneous_3197640356 pubmed_primary_40300562 crossref_primary_10_1159_000546065 |
PublicationCentury | 2000 |
PublicationDate | 2025-04-29 |
PublicationDateYYYYMMDD | 2025-04-29 |
PublicationDate_xml | – month: 04 year: 2025 text: 2025-04-29 day: 29 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel, Switzerland |
PublicationTitle | Intervirology |
PublicationTitleAlternate | Intervirology |
PublicationYear | 2025 |
Publisher | S. Karger AG |
Publisher_xml | – name: S. Karger AG |
References | ref13 ref57 ref12 ref56 ref15 ref14 ref53 ref52 ref11 ref55 ref10 ref54 ref17 ref16 ref19 ref18 ref51 ref50 ref46 ref45 ref48 ref47 ref42 ref41 ref44 ref43 ref49 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 ref35 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref2 ref1 ref39 ref38 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 |
References_xml | – ident: ref2 doi: 10.3390/vaccines8030341 – ident: ref55 doi: 10.1186/s12879-022-07542-9 – ident: ref17 doi: 10.1186/s12879-021-05795-4 – ident: ref46 doi: 10.1016/j.vaccine.2018.08.081 – ident: ref28 doi: 10.1097/00006454-198603000-00012 – ident: ref23 doi: 10.1002/jmv.27806 – ident: ref32 doi: 10.2807/1560-7917.ES.2019.24.15.1800418 – ident: ref4 doi: 10.1136/archdischild-2017-313163 – ident: ref51 doi: 10.1002/jmv.25214 – ident: ref39 doi: 10.1016/j.vaccine.2018.08.046 – ident: ref24 doi: 10.3201/eid2803.212117 – ident: ref3 doi: 10.1093/jpids/piw071 – ident: ref9 doi: 10.1016/j.vaccine.2019.03.069 – ident: ref25 doi: 10.1007/s44197-022-00050-8 – ident: ref20 doi: 10.1016/j.jinf.2015.03.001 – ident: ref45 doi: 10.1186/s12879-020-05279-x – ident: ref11 doi: 10.1016/j.cmi.2016.06.007 – ident: ref6 doi: 10.1080/21645515.2020.1801071 – ident: ref30 doi: 10.4415/ANN_13_02_03 – ident: ref5 doi: 10.1590/0037-8682-0023-2015 – ident: ref38 doi: 10.1093/cid/ciy1096 – ident: ref48 doi: 10.11604/PAMJ.SUPP.2017.28.1.2486 – ident: ref16 doi: 10.1002/rmv.2020 – ident: ref52 doi: 10.1186/s12929-020-00649-8 – ident: ref21 doi: 10.1016/j.lanwpc.2021.100268 – ident: ref26 doi: 10.1136/BMJ-2021-066169 – ident: ref15 doi: 10.4269/ajtmh.18-0763 – ident: ref18 doi: 10.1186/s12879-018-3411-3 – ident: ref14 doi: 10.1371/journal.pone.0242813 – ident: ref56 doi: 10.1007/s00705-023-05849-9 – ident: ref42 doi: 10.1186/s12879-020-05448-y – ident: ref44 doi: 10.1099/jgv.0.000807 – ident: ref34 doi: 10.1186/s12879-020-05230-0 – ident: ref40 doi: 10.1016/j.vaccine.2018.05.031 – ident: ref37 doi: 10.1017/S0950268820002320 – ident: ref31 doi: 10.2807/1560-7917.ES.2019.24.6.1700774 – ident: ref49 doi: 10.1016/j.vaccine.2014.06.018 – ident: ref33 doi: 10.1016/j.cmi.2017.10.009 – ident: ref19 doi: 10.1002/jmv.25530 – ident: ref53 doi: 10.3390/tropicalmed8020101 – ident: ref50 doi: 10.1007/s00705-013-1663-1 – ident: ref22 doi: 10.1016/j.jinf.2021.09.007 – ident: ref36 doi: 10.1186/s12879-020-05718-9 – ident: ref41 doi: 10.1002/jmv.25067 – ident: ref8 doi: 10.1053/j.spid.2006.08.005 – ident: ref47 doi: 10.1007/s12250-018-0043-0 – ident: ref57 doi: 10.1016/j.heliyon.2023.e18236 – ident: ref43 doi: 10.7717/peerj.10954 – ident: ref54 doi: 10.3390/ijms241512189 – ident: ref35 doi: 10.1016/j.vaccine.2019.09.022 – ident: ref13 doi: 10.1186/s12889-019-6406-0 – ident: ref29 doi: 10.1016/j.jes.2017.07.015 – ident: ref10 doi: 10.1128/JVI.02076-17 – ident: ref12 doi: 10.1002/ece3.5015 – ident: ref7 doi: 10.2165/11207130-000000000-00000 – ident: ref1 doi: 10.1001/jamapediatrics.2018.1960 – ident: ref27 doi: 10.1073/pnas.2013182117 |
SSID | ssj0003130 |
Score | 2.3938034 |
Snippet | Background: Rotavirus (RV) A is one of the major reasons which causes acute dehydration and diarrhea. It is also one of the highest morbid diseases in... Rotavirus (RV) A is one of the major reasons which causes acute dehydration and diarrhea. It is also one of the highest morbid diseases in children. There are... Rotavirus(RVs) A is one of major reasons which causes severe dehydration diarrhea. It is also one of the high morbidity disease in children. There are only a... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 43 |
SubjectTerms | Antigenic Variation Antigens, Viral - genetics Antigens, Viral - immunology Capsid Proteins - genetics Capsid Proteins - immunology Child, Preschool China - epidemiology Epitopes - genetics Feces - virology Genetic Variation Genotype Humans Infant Phylogeny Prevalence Rotavirus - classification Rotavirus - genetics Rotavirus - immunology Rotavirus - isolation & purification Rotavirus Infections - epidemiology Rotavirus Infections - virology Sequence Analysis, DNA |
Title | Genetic and Antigenic Variability in VP4 and VP7 of Group A Human Rotavirus in Yunnan, China, from 2015 to 2020 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40300562 https://www.proquest.com/docview/3197640356 https://pubmed.ncbi.nlm.nih.gov/PMC12237282 |
Volume | 68 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiQuiDflJYM4biBxbMc5VitQhVS0ErvVcoocx1ZzSdCSrNS98c8ZP5KmWw4Ll6hN7aT1fJ1XZj4j9CGvuMq1pcfTkkfUKBVJo3hUpSbLlGGUK5vvWH3jy3P69YJdzGa_p90lXflRXf-1r-R_pArnQK62S_YfJDteFE7Aa5AvHEHCcLyVjC1n9EC4umg6S6wJ79YQ_nr2bdfTtz6lbsD6NLOeoc8-LYbsfdvJq_qyd1WxP8CZleEhfO17xVz3CVhvZn1UEpN46sy6bKLtk5tm5ldu3lK2236XrPcKZaVrs-s8O9n0oe-h7o0MBtSWBoUi4e-bfjvY1ZCWIMw-YQm5i9COFccRYyTwXHvtCr5bBAFgPFW_XBzAzOtST98UrLJnHz_U9yz3BZIAqthvOrHPqX3D1o0ViC72YXkxTr2D7hKINMgQlQdjniZuu5rx1wRyKpj6aZy679IcxCk3y20n_svZQ_QgBB544VH0CM108xjd81uRbp-gNmAJA1TwiCU8wRKuGwxYcgMAS7g12GEJL7DDEh6xZEd6LB1jh6RjbHGELY5w12KLo6fo_Mvns5NlFDbjiFSaii5KciOEqXiuLL2RFBAGVNoQaXgpSMJ1WUrFWJaaSueMSKUET7kkppJZxTSh6TN01LSNfoHgLrGCpSSUaUEp-JhGsbiiCTHSbpCm5-j9sJ7FT8-5UhzIa47eDStdgEa0j7lko9v-VwFGJeM0Thmfo-d-5cfLUCtIcPnnSOzJZBxg2db3P2nqjWNdT8CRzoggL2_z7V6h-7s_xWt01F32-g14r1351uHrD8VvlEo |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetic+and+Antigenic+Variability+in+VP4+and+VP7+of+Group+A+Human+Rotavirus+in+Yunnan%2C+China%2C+from+2015+to+2020&rft.jtitle=Intervirology&rft.au=Ma%2C+Haoyu&rft.au=Wang%2C+Meifen&rft.au=Chuan%2C+Liufang&rft.au=Long%2C+Shuying&rft.date=2025-04-29&rft.issn=0300-5526&rft.eissn=1423-0100&rft.volume=68&rft.issue=1&rft.spage=43&rft.epage=56&rft_id=info:doi/10.1159%2F000546065&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000546065 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-5526&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-5526&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-5526&client=summon |